Effects of casirivimab/imdevimab on systemic and mucosal immunity against SARS-CoV-2 in B-cell depleted patients with autoimmune rheumatic diseases refractory to vaccination
oleh: Georg Schett, Bernhard Manger, Thomas Harrer, Filippo Fagni, Arnd Kleyer, Larissa Valor-Méndez, Karin Manger, David Simon, Koray Tascilar, Katja Schmidt, Daniela Bohr, Fabian Hartmann
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2022-05-01 |
Deskripsi
No description available for this item.